🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Elimination

According to TikTok, the service has removed problematic content and banned associated hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

Within moments of joining one community, a vendor posted contact information, where most transactions take place. The seller sent an guidebook and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, health issues or previous experience.

Item Information and Costs

Within these groups, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.